Investment Summary |
|
|---|---|
| Date | 2020-05-07 |
| Target | Atento |
| Sector | Business Services |
| Investor(s) |
HPS Investment Partners
Farallon Capital Management |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Lender |
|---|---|
| Founded | 2007 |
| PE ASSETS | 104.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
HPS Investment Partners is a global investment firm that seeks to provide capital solutions clients. The Firm manages various strategies across the capital structure that include syndicated leveraged loans and high yield bonds to privately negotiated senior secured debt and mezzanine investments, asset-based leasing and private equity. The Firm looks to invest in companies large and small, through standard or customized solutions. HPS was formed in 2007 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 10 |
| Sector: Business Services M&A | 1 of 2 |
| Type: Stake Purchase M&A Deals | 1 of 1 |
| Country: Luxembourg M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-11-19 |
Spruce Power
Houston, Texas, United States Spruce Power owns and operates more than 52,000 residential rooftop solar systems. The company sells the power generated by its systems to homeowners pursuant to long-term agreements that obligate the company’s subscribers to make recurring monthly payments. Spruce Power is headquartered in Houston, Texas. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-04-19 |
Marlin Capital Solutions
Mount Laurel, New Jersey, United States Marlin Capital Solutions is a nationwide provider of capital solutions to small businesses with a mission of helping small businesses fulfill their American dream. Our products and services are offered directly to small businesses and through financing programs, with independent equipment dealers and other intermediaries. Marlin Capital Solutions was founded in 1997 and is based in Mount Laurel, New Jersey. |
Buy | - |
| Category | Asset Manager |
|---|---|
| Founded | 1986 |
| Size | Large |
| Type | Sector Agnostic |
Farallon Capital Management is a private investment firm that targets a variety of investment strategies throughout the world. The Firm pursues investments that include public and private debt and equity securities, direct investments in private companies, and real estate. Farallon is especially interested in investments that include a key event (such as a merger, restructuring, recapitalization or other major change) that has the potential for an appreciation of the value of a particular investment. Farallon's direct investment group makes debt, preferred stock or equity investments in businesses with substantial franchise value, healthy cash flow, and motivated management who have invested alongside the Firm. Farallon Capital Management was formed in 1986 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 11 |
| Sector: Business Services M&A | 1 of 1 |
| Type: Stake Purchase M&A Deals | 1 of 1 |
| Country: Luxembourg M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-11-15 |
Contech Engineered Solutions
West Chester, Ohio, United States Contech Engineered Solutions is a provider of engineering and site solutions for the residential, commercial and infrastructure markets. The company's primary end markets are the US infrastructure, commercial and residential construction markets. Contech Engineered Solutions was formed in 1986 and is based in West Chester, Ohio. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-07-15 |
BioAtla
San Diego, California, United States BioAtla is a clinical-stage biopharmaceutical company developing a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. BioAtla was founded in 2007 and is based in San Diego, California. |
Buy | - |
